Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Merck
Colorcon
Mallinckrodt
Boehringer Ingelheim

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Litigation Details for Tris Pharma Inc. v. Par Pharmaceutical Inc. (D. Del. 2015)

See Plans and Pricing

« Back to Dashboard

Tris Pharma Inc. v. Par Pharmaceutical Inc. (D. Del. 2015)

Docket   Start Trial Date Filed 2015-01-21
Court District Court, D. Delaware Date Terminated 2015-11-02
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties PAR PHARMACEUTICAL COMPANIES INC.; PAR PHARMACEUTICAL INC.; TRIS PHARMA INC.
Patents 8,062,667; 8,287,903; 8,465,765; 8,563,033; 8,778,390
Attorneys Derek James Fahnestock; Jack B. Blumenfeld; Steven J. Fineman
Link to Docket External link to docket
Small Molecule Drugs cited in Tris Pharma Inc. v. Par Pharmaceutical Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Tris Pharma Inc. v. Par Pharmaceutical Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-01-21 1 infringement of United States Patent No. 8,062,667 (“the ’667 patent”), United States Patent No. 8,287,903 (“the…extended release oral suspension United States Patent Nos. 8,062,667; 8,287,903; 8,465,765; 8,563,033 and 8,…extended release oral suspension United States Patent Nos. 8,062,667; 8,287,903; 8,465,765; 8,563,033 and 8,…infringed the ’667 patent, the ’903 patent, ’765 patent, the ’033 patent, and the ’390 patent by submitting… of the ’667 patent, the ’903 patent, ’765 patent, the ’033 patent, and the ’390 patent; (d) External link to document
2015-01-21 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,062,667 B2; 8,827,903 B2; 8,465,765…2015 2 November 2015 1:15-cv-00068 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
AstraZeneca
Mallinckrodt
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.